400-82-02
8.6
[]. A Louie, et al. Pharmacodynamics of fluconazole in a murine model of systemic candidiasis. Antimicrob Agents Chemother. 998 May;42():0-9.
[2]. H Yamaguchi, et al. [In vitro activity of fluconazole, a novel bistriazole antifungal agent]. Jpn J Antibiot. 989 Jan;42():-6.
[3]. M A Pfaller, et al. Interpretive breakpoints for fluconazole and <i>Candida</i> revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev. 2006 Apr;9(2):43-4.
[4]. P G Sohnle, et al. Effect of fluconazole on viability of Candida albicans over extended periods of time. Antimicrob Agents Chemother. 996 Nov;40():2622-.
[]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 209;3(2):2-26.
H302-H3-H39-H33
P26-P264-P20-P2-P280-P302+P32-P304+P340-P330-P362+P364-P40-P0
GHS0
04069 货期咨询
￥ űƞŠǣǣ -g
3094 货期咨询
300 货期咨询
9849 货期咨询
3096 货期咨询
30924 货期咨询
3094 货期咨询
3089 货期咨询
30933 货期咨询
￥ ƓǔűŠǣǣ -0mg
20466 货期咨询
￥ ƓķņƞŠǣǣ -g
沪ICP备0964号
